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The widespread use of the Internet and electronic publish-
ing has contributed to the evolution of open-access
journals, including those in the field of ophthalmic
research. Such peer-reviewed electronic publications are
highly desirable since they encourage the rapid publication
of basic and clinical research, unlike the traditional paper
journals. Timely publication of research without substantial
delay will help ensure the rapid translation of basic and
clinical studies to the bedside, introducing diagnostic and
therapeutic interventions in the management of complex
ocular inflammations and infections. Clearly, online open-
access journals represent the future direction of publishing
for the dissemination of biomedical research and the ever-
changing approaches to diagnosis and therapeutic interven-
tion. Moreover, open-access electronic publications are
easily retrieved, without the imposition of financial con-
straints at either the institutional or the individual level, in
both the developed and the developing world. Since
infectious diseases are more prevalent in developing
countries, access to peer-reviewed electronic journals offers
the opportunity for prompt publication of emerging
infectious diseases from various geographic regions, as
well as for continued education for clinicians practicing in
such countries and in the rest of the world. The ability of
electronic journals to offer cost–effective, timely publica-
tion with abundant high-quality illustrations will enhance
patient care by allowing the timely recognition of ophthal-
mic inflammatory conditions. Emerging imaging technolo-
gy is transforming the diagnosis and classification of
various ophthalmic disorders, including intraocular inflam-
mations, and is providing in vivo illustrations of the
pathologic process; the further characterization of ocular
inflammation with the aid of imaging methods should
advance the current management of inflammatory process-
es. For such advancement, electronic journals offer the
publication of images with minimal or no cost to authors.
The above advantages of electronic publication will no
doubt have a significant impact in the ophthalmic field in
general and in ocular inflammation and infection in
particular. This impact is becoming obvious since open-
access articles are cited more often than non-open-access
traditional journals. The increased use translates into a
substantial increase in the impact of a publication.
Under the leadership of Professors Phuc LeHoang, Jorge
Alio, and Talin Barisani-Asenbauer, the International
Ocular Inflammation and Infection society (IOIS) decided
to initiate an electronic journal to the benefit of members
and non-members interested in the field of ophthalmic
inflammation and infection. An election was held in 2007,
during the annual IOIS business meeting held during the
IOIS congress in Paris, France, to choose the editor-in-chief
for such a journal
As editor-in-chief of the journal, my first task was to
select the editorial board members. This was not an easy
task since there were several IOIS members and others with
remarkable expertise. Thus, the selection of the current
board members reflects their expertise, the fairness of their
reviewing process, and their high ethical standards. More-
over, to reflect the global nature of the new journal, we
have attempted a fair distribution of the editorial board to
represent different geographical areas. All of the board
members enthusiastically support the common goal of
improving patient care in ophthalmic inflammation and
infections through the prompt review of articles that are
clinically relevant and preferably evidence-based.
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Our mission in launching this new journal is to provide fair
review and prompt publication of relevant articles, including
high-quality images, without cost to authors. Moreover,
priority will be given to expedited publication of those articles
which provide cutting-edge clinical details for improving the
care of patients with ocular inflammation and infections. To
accomplish these goals, the submitted manuscripts will be
reviewed briefly by the editor-in-chief for relevance of content
and then assigned to expert reviewers from among a pool of
IOIS and other ocular inflammation society members. If
required, additional experts outside the field of ocular
infection will be invited as reviewers. Every attempt will be
made to obtain a minimum of two reviews, and based on the
reviewers’ recommendations, the manuscript will be graded as
A—accept as is; B—minor revision required; C—major
revision required; or D—reject. The editor-in-chief will go
over the reviews for fairness and make a final judgment. The
entire process from submission to final judgment should be
around 6–8 weeks, and the accepted papers will appear in the
electronic journal within 3 months. Although we will strive to
deliver the journal once a month, during the next 12–
24 months, we will limit the number of issues to four until
the current pace of high-quality manuscripts submission is
enhanced.
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